Engitix Ltd

About Engitix Ltd

Engitix is focused on reshaping drug discovery for fibrosis and cancer by decoding the Extracellular Matrix (ECM) space to unlock unprecedented therapies for chronic diseases. They utilize tissue- and disease-specific human ECM scaffolds to study disease mechanisms and develop therapies targeting inflammation, fibrosis, and solid tumors.

Products & Services

ECM Platform:A unique platform technology using tissue- and disease-specific human ECM scaffolds to model and study disease biology mechanisms.

Pipeline:A portfolio of assets in the discovery stage targeting disease-specific changes in the ECM to improve clinical outcomes in fibrosis, inflammation, and solid tumors.

Partnerships:Collaborations with pharma and biotech companies to expand the discovery potential of their platform into additional therapeutic areas.

Specialties

Extracellular Matrix (ECM) research Drug discovery for fibrosis Drug discovery for cancer Therapeutic targets for chronic diseases

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Series A Extension T: - FT: Series A Extension	A: 25000000 MR: - FA: $25 million FAN: 25000000	D: 2026-01-08 FD: 2026-01-08	1 investors

Series A Extension Latest

2026-01-08

$25.0M

1 investor (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

G

Giuseppe Mazza

Chief Executive Officer and Co-Founder

C

Chris Stevenson, PhD

Chief Scientific Officer

M

Matt Edwards

SVP, Discovery

E

Emma Huang

VP of Platform and Technology

A

Amélie Fortin

Head of People & Culture

A

Andy Roland-Price

Head of Finance

View 20 more team members with Pro

Unlock Full Team Directory

Recent News

Engitix Ltd Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised